Literature DB >> 29626078

Early Cardiac Involvement Affects Left Ventricular Longitudinal Function in Females Carrying α-Galactosidase A Mutation: Role of Hybrid Positron Emission Tomography and Magnetic Resonance Imaging and Speckle-Tracking Echocardiography.

Letizia Spinelli1, Massimo Imbriaco2, Carmela Nappi2, Emanuele Nicolai2, Giuseppe Giugliano2, Andrea Ponsiglione2, Tommaso Claudio Diomiaiuti2, Eleonora Riccio2, Giovanni Duro2, Antonio Pisani2, Bruno Trimarco2, Alberto Cuocolo2.   

Abstract

BACKGROUND: Hybrid 18F-fluorodeoxyglucose (FDG) positron emission tomography and magnetic resonance imaging may differentiate mature fibrosis or scar from fibrosis associated to active inflammation in patients with Anderson-Fabry disease, even in nonhypertrophic stage. This study was designed to compare the results of positron emission tomography and magnetic resonance cardiac imaging with those of speckle-tracking echocardiography in heterozygous Anderson-Fabry disease females. METHODS AND
RESULTS: Twenty-four heterozygous females carrying α-galactosidase A mutation and without left ventricular hypertrophy underwent cardiac positron emission tomography and magnetic resonance using 18F-FDG for glucose uptake and 2-dimensional strain echocardiography. 18F-FDG myocardial uptake was quantified by measuring the coefficient of variation (COV) of the standardized uptake value using a 17-segment model. Focal 18F-FDG uptake with COV >0.17 was detected in 13 patients, including 2 patients with late gadolinium enhancement at magnetic resonance. COV was 0.30±0.14 in patients with focal 18F-FDG uptake and 0.12±0.03 in those without (P<0.001). Strain echocardiography revealed worse global longitudinal systolic strain in patients with COV >0.17 compared with those with COV ≤0.17 (-18.5±2.7% versus -22.2±1.8%; P=0.024). For predicting COV >0.17, a global longitudinal strain >-19.8% had 77% sensitivity and 91% specificity and a value >2 dysfunctional segments 92% sensitivity and 100% specificity.
CONCLUSIONS: In females carrying α-galactosidase A mutation, focal 18F-FDG uptake represents an early sign of disease-related myocardial damage and is associated with impaired left ventricular longitudinal function. These findings support the hypothesis that inflammation plays an important role in glycosphingolipids storage disorders.
© 2018 American Heart Association, Inc.

Entities:  

Keywords:  fibrosis; gadolinium; heart; inflammation; mutation

Mesh:

Substances:

Year:  2018        PMID: 29626078     DOI: 10.1161/CIRCIMAGING.117.007019

Source DB:  PubMed          Journal:  Circ Cardiovasc Imaging        ISSN: 1941-9651            Impact factor:   7.792


  9 in total

1.  Cardiac amyloidosis: A new challenge of multimodality imaging.

Authors:  Carmela Nappi; Roberta Assante; Emilia Zampella; Alberto Cuocolo
Journal:  J Nucl Cardiol       Date:  2018-06-26       Impact factor: 5.952

2.  Focal reduction in left ventricular 123I-metaiodobenzylguanidine uptake and impairment in systolic function in patients with Anderson-Fabry disease.

Authors:  Letizia Spinelli; Massimo Imbriaco; Giuseppe Giugliano; Carmela Nappi; Valeria Gaudieri; Eleonora Riccio; Antonio Pisani; Bruno Trimarco; Alberto Cuocolo
Journal:  J Nucl Cardiol       Date:  2019-05-13       Impact factor: 5.952

3.  New insights for early assessment of cardiac involvement in Anderson-Fabry disease.

Authors:  Alberto Cuocolo; Carmela Nappi; Valeria Gaudieri; Antonio Pisani; Massimo Imbriaco
Journal:  J Nucl Cardiol       Date:  2019-02-06       Impact factor: 5.952

Review 4.  Fabry Disease and the Heart: A Comprehensive Review.

Authors:  Olga Azevedo; Filipa Cordeiro; Miguel Fernandes Gago; Gabriel Miltenberger-Miltenyi; Catarina Ferreira; Nuno Sousa; Damião Cunha
Journal:  Int J Mol Sci       Date:  2021-04-23       Impact factor: 5.923

5.  Major Organic Involvement in Women with Fabry Disease in Argentina.

Authors:  Fernando Perretta; Norberto Antongiovanni; Sebastián Jaurretche
Journal:  ScientificWorldJournal       Date:  2018-05-21

Review 6.  Storage diseases with hypertrophic cardiomyopathy phenotype.

Authors:  Luis Ruiz-Guerrero; Roberto Barriales-Villa
Journal:  Glob Cardiol Sci Pract       Date:  2018-08-12

Review 7.  Cardiac Imaging in Anderson-Fabry Disease: Past, Present and Future.

Authors:  Roberta Esposito; Ciro Santoro; Giulia Elena Mandoli; Vittoria Cuomo; Regina Sorrentino; Lucia La Mura; Maria Concetta Pastore; Francesco Bandera; Flavio D'Ascenzi; Alessandro Malagoli; Giovanni Benfari; Antonello D'Andrea; Matteo Cameli
Journal:  J Clin Med       Date:  2021-05-06       Impact factor: 4.241

Review 8.  Multimodality imaging approach to Fabry cardiomyopathy: Any role for nuclear cardiology?

Authors:  Wanda Acampa; Adriana D'Antonio; Massimo Imbriaco; Antonio Pisani; Alberto Cuocolo
Journal:  J Nucl Cardiol       Date:  2020-05-06       Impact factor: 3.872

9.  Does left ventricular function predict cardiac outcome in Anderson-Fabry disease?

Authors:  Letizia Spinelli; Giuseppe Giugliano; Antonio Pisani; Massimo Imbriaco; Eleonora Riccio; Camilla Russo; Alberto Cuocolo; Bruno Trimarco; Giovanni Esposito
Journal:  Int J Cardiovasc Imaging       Date:  2020-11-19       Impact factor: 2.357

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.